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Abstract Understanding the mechanism of developmental brain injury is crucial for the progress of discovering neu-
roprotective strategies and interventions. However, the pathophysiology is complex which involves interactions and 
crosstalk of diverse neural cell types. Isolating viable and pure populations of these brain cells is a valuable tool to 
study the particular cell properties and understand the physiologic and pathophysiologic mechanisms. Here we present 
a magnetic cell sorting approach to separate astrocytes and neurons sequentially from the same neonatal (postnatal 
day 9 or 10) CD-1 mouse brain samples. The procedure which involves positive selection of astrocytes by the ACSA-2 
antibody followed by a negative depletion of non-neuronal cells from the flow through yields relatively enriched neuronal 
cells. The sorted fractions are highly pure and viable and can be used for further applications and analyses.
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BACKGROUND
Understanding the physiologic and pathologic mechanisms under-
lying developmental brain injury is challenging. Many types of cells 
contribute to the processes including neurons, astrocytes, microglia and 
oligodendrocytes. There is crosstalk and paracrine signaling in neural 
cells during the injury process that still remains to be investigated. 
Particularly astrocytes and neurons show a wide range of interactions 
important not only for synaptogenesis, modulation of neurotransmission 
[1], energy storage [2] and detoxification  [3], but also for intrinsic injury 
repair  [4]. Revealing this endogenous neuroprotective potential might 
lead to the development of new therapeutic strategies to attenuate or 
prevent irreversible neuronal injury to the developing brain. Isolation of 
diverse neural cell types from acutely injured brains therefore, permits 
the detailed study of mechanisms related to these interactions. 
During the last three decades, magnetic cell sorting (MACS) and 
fluorescence-activated cell sorting (FACS) have been established as 
state-of-the-art cell isolation technologies [5]. The advantages of MACS 
are the high separation capacity [6], the speed of processing, excellent 
purity and minimal stress to the cells[5]. It is based on high gradient 
magnetic cell separation with super-paramagnetic microparticles, a 
concept first described by Molday and Molday in 1984 [7]. Miltenyi 
and colleagues subsequently optimized this method and published 
and patented it in 1990 [6]. Cells are immunologically labeled with 
super-paramagnetic nanoparticles and applied to separation columns 
containing ferromagnetic steel wool. By placing these columns in a 
magnetic field, the labeled cells are attracted to the magnet, retained 
in the columns, and may thus be separated from the unlabeled cells. 
Elution of the labeled cells is possible after removing the column from 
the magnetic field [5]. 
MACS technology has been increasingly used in neuroscience 
research. In this protocol, instead of isolating neurons and astrocytes 
separately from different brains, we describe a novel application of 
magnetic cell sorting approach to purify them sequentially from the 
same mouse brain sample. For astrocytes, we used the ACSA-2 an-
tibody, which specifically recognizes an epitope that is comparably 
expressed as the astrocyte-specific L-glutamate/L-aspartate transporter 
GLAST (EAAT1, Slc1a3) [8,9]we describe a new monoclonal antibody, 
ACSA-1, which was generated by immunization of GLAST1 knockout 
mice. The antibody specifically detects an extracellular epitope of the 
astrocyte-specific L-glutamate/L-aspartate transporter GLAST (EAAT1, 
Slc1a3. The use of ACSA-2 microbeads with magnetic separation col-
umns allows the isolation of pure astrocytes by positive selection from 
brain single-cell suspension. Pure neurons are acquired by ‘depletion’ 
of non-neuronal cells from the flow through after removal of astrocytes 
[10]. This method allows direct comparison and accurate analysis of 
cell type-specific physiological function and response to injuries. 
MATERIALS
Animals 
Postnatal day 9 or 10 (P9 or P10) old CD-1 mice were used (Harlan 
Labs, Livermore, CA, USA). Animal research was approved by the 
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University of California San Francisco Institutional Animal Care and 
Use Committee and was performed with the highest standards of care 
under the U.S. National Institutes of Health guidelines. The pups were 
euthanized and perfused for collection of brain tissue. 40 µl of Euthasol 
for each mouse was used to achieve unresponsiveness to paw pinch. 
10 ml ice cold HBSS with Ca2+ and Mg2+ at a perfusion pump speed 
of 5 ml/min was used for transcardial perfusion of the brain before 
tissue removal. 
Equipment 
 9 GentleMACS Dissociator (Miltenyi Biotec, San Diego, CA, 
USA, # 130-093-235)
 9 OctoMACS Separator (Miltenyi Biotec, # 130-042-109) (suitable 
magnet for MS column)
 9 QuadroMACS Separator (Miltenyi Biotec, # 130-090-976) (suit-
able magnet for LS Column)
 9 2 fire polished glass Pasteur pipettes (ca. 0.7 mm and 1 mm 
diameter)
 9 Centrifuge (suitable for 15 and 50 ml tubes)
 9 15 ml centrifuge tubes 
 9 Pre-Separation Filters (70 µm) (Miltenyi Biotec, # 130-095-823)
 9 LS Columns (Miltenyi Biotec, # 130-042-401)
 9 MS Columns (Miltenyi Biotec, # 130-042-201)
 9 C Tubes (Miltenyi Biotec, # 130-093-237)
 9 Hemocytometer for cell counting
Reagents 
 9 Neural Tissue Dissociation Kit Postnatal Neurons (Miltenyi 
Biotec, # 130-094-802)
 9 Myelin Removal Beads II, human, mouse, rat (Miltenyi Biotec, 
# 130-096-733)
 9 Anti-ACSA-2 MicroBead Kit (Miltenyi Biotec, # 130-097-678)
 9 Neuron Isolation Kit (Miltenyi Biotec, # 130-098-752)
 9 D-PBS with Ca2+ and Mg2+ (Invitrogen, Grand Island, NY, USA, 
# 14040-133)
 9 PBS (Cell Culture Facility (CCF), University of California San 
Francisco)
 9 HBSS with Ca2+ and Mg2+ (CCF) 
 9 Bovine Serum Albumin (BSA) (Merck Millipore, Billerica, MA, 
USA, # 126609)
 9 Euthasol (Virbac AH, Fort Worth, TX, USA, # 200-071)
 9 BD BioCoat 96-well plate (Becton Dickinson, Franklin Lake, 
NJ, USA, # 356461)
 9 Paraformaldehyde (Fisher Scientific, Pittsburg, PA, USA, # 
04042-500)
 9 Neurobasal Medium (Life Technologies, Carlsbad, CA, USA, 
# 12348-017)
 9 B-27 Supplement (Life Technologies, # 17504-044)
 9 GlutaMax Supplement (Life Technologies, 35050-061)
 9 NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce, 
Rockford, IL, USA, # 78833)
 9 BCA Protein Assay Reagent (Pierce, # 23228)
 9 LIVE/DEAD Viability/Cytotoxicity Kit (Invitrogen, # L-3224).
 9 Anti-Glial Fibrillary Acidic Protein Antibody, mouse monoclonal 
(Merck Millipore, 1:100, # MAB3402)
 9 Anti-Glial Fibrillary Acidic Protein, rabbit polyclonal (Dako, 
Carpinteria, CA, 1:500, # Z0334)
 9 Doublecortin, mouse monoclonal (Santa Cruz Biotechnology, 
Santa Cruz, CA, 1:100, # sc-271390)
 9 Anti Iba-1, rabbit polyclonal (Wako Chemicals, Richmond, VA, 
1:500, # 019-90741)
 9 Anti-MAP2, mouse monoclonal (abcam, Cambridge, MA, 1:500, 
# ab11267)
PROCEDURE
The following procedure is based on a Magnetic Cell Sorting Technique with reagents and instruments purchased from Miltenyi Biotech. 
This method follows mainly the manufacturer’s protocol, we focused here on steps with novel and significant modifications and integration of 
separate procedures of astrocyte and neuron isolation for sequential purification from the same brain samples. 
In order to improve cell viability and increase cell yield, pre-cooled reagents should be used to avoid antibody internalization by the cells 
[11]. Even the tubes and separation columns can be pre-chilled at 4°C. 
In this protocol, 4 cortical hemispheres were combined to achieve a cell yield that allows extracting enough protein for western blot analysis. 
Tissue Dissociation
1. Collect the brains of the transcardially perfused mice in HBSS with Ca2+ and Mg2+ and place the samples on ice. 
2. Dissect the brains and collect the cortices in D-PBS with Ca2+ and Mg2+ (DPBS w) and place the samples on ice. 
3. Perform Neural Tissue Dissociation according to the manufacturer´s protocol, by using the C Tubes and the Gen-
tleMACS Dissociator. 
4. Caution: Tissue pieces can stick to the wall of the C Tube and not be dissociated properly. 
5. Combining the automated dissociation with manual trituration with the fire polished pipettes can increase the yield. 
The last addition of enzyme mix 2 should therefore be followed by a short centrifugation to collect the cells at the 
bottom of the tube (30 s at 300 × g). 
J Biol Methods  | 2014 | Vol. 1(2) | e11 3
POL Scientific
6. Use the bigger Pasteur pipette (ca. 1 mm diameter) after rinsing with DPBS w + 0.5% BSA and slowly pipette the 
cell solution 10 - 15 times up and down. No air bubbles should be formed. Repeat with the smaller pipette (ca. 
0.7 mm diameter). 
7. Tip: The sample should turn into a milky solution without observable tissue pieces. 
8. Prepare a 15 ml tube with a 70 µm Pre-Separation Filter by rinsing with 1 ml of DPBS w + 0.5% BSA before the 
cell suspension is applied onto the strainer. Use 10 ml of DPBS w + 0.5% BSA to rinse the C Tube, recollect the 
buffer and apply it onto the filter. 
9. Spin the solution for 15 min at 300 × g at room temperature. 
10. Remove the supernatant carefully and proceed to the Myelin Removal step.
Myelin Removal
11. Resuspend the cell pellet in 360 µl of PBS supplemented with 0.5% BSA and add 40 µl of Myelin Removal Beads 
and incubate for 15 min at 2-8°C. Agitate the tube every 5 min to assure homogenous binding of the antibodies. 
Then wash the solution by adding 2000 µl of PBS + 0.5% BSA. 
12. Spin the cells for 10 min at 300×g at room temperature.
13. Prepare the LS Column with a 70 µm Pre-Separation Filter by rinsing with 3 ml of PBS + 0.5% BSA. 
14. Resuspend the cell pellet in 1000 µl of PBS + 0.5% BSA and apply it onto the cell column. 
15. Wash the column with 2 × 1 ml of PBS + 0.5% BSA and collect the flow through which contains the unlabeled cells. 
16. Perform a cell count using a hemocytometer to keep track of your yield. 
Astrocyte Separation
17. Spin the cells for 10 min at 300 × g at room temperature and aspirate the supernatant carefully. 
18. Resuspend the pellet in 160 µl of PBS + 0.5 % BSA and add 20 µl FcR Blocking Reagent. After 10 min incubation 
at 2-8°C, add 20 µl Anti-ACSA-2 MicroBeads and incubate for another 15 min. Manual agitation of the tubes by 
gentle flipping can help to equally label the cells. 
19. Add 4 ml of PBS + 0.5% BSA to the cells, spin them down for 10 min at 300 × g at room temperature and aspirate 
the supernatant. 
20. Resuspend the pellet in 1 ml of PBS + 0.5% BSA and pipette the cell suspension onto a LS Column rinsed with 
3 ml of the resuspension buffer. 
21. Wash the column with 3 × 3 ml of PBS + 0.5% BSA. Collect the flow through since it contains the unlabeled cells 
for further isolation of neurons. 
22. Remove the LS Column that contains the retained astrocytes from the magnetic field and place it on a collection 
tube. Immediately pipette 6 ml of pre-equilibrated and pre-warmed cell medium onto the reservoir of the column 
(Alternatively, appropriate buffers can be used to elute the cells depending on the downstream applications).
23. Press the plunger onto the columns and elute the ACSA-2 labeled cells. 
NOTE: A high flow rate helps to elute the cells from the column. 
24. Perform a cell count using a hemocytometer.
Neuron Separation
25. Centrifuge the flow through from step 19 which contains the unlabeled cells at 300×g for 8 min. Remove the 
supernatant and resuspend the cell pellet in 80 µl of DPBS w + 0.5% BSA.
26. Add 20 µl of Non-Neuronal Cells Biotin-Antibody Cocktail and incubate for 5 min at 2-8°C. 
27. Wash the cells with 1 ml of DPBS w + 0.5% BSA and spin them down at 300 × g for 8 min. 
28. After aspiration of the supernatant add 80 µl of DPBS w + 0.5% BSA to the cell pellet and incubate with 20 µl of 
Anti-Biotin MicroBeads for 10 min at 2-8°C. 
29. Prepare a MS Column by rinsing with 500 µl of DPBS w + 0.5% BSA. 
30. Fill the sample volume up to 500 µl with DPBS w and apply it onto the MS Column placed in the magnetic field. 
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31. Wash the column with 2 × 500 µl of DPBS w + 0.5% BSA. Collect the flow through as it contains the non-labeled 
neuronal cells. 
32. Spin the collected solution down at 300 × g for 10 min and resuspend the cells in pre-equilibrated and pre-warmed 
culture medium or an appropriate buffer depending on further applications. 
33. Perform a cell count using a hemocytometer.
ANTICIPATED RESULTS
Cell and Protein Yield
The cell yield was determined by cell counts immediately after 
isolation of the respective fractions. Around 1 × 106 ACSA-2-positive 
astrocytes, and around 0.45 × 106 neurons were obtained per P9-P10 
CD-1 mouse brain (n=2) (Table 1). Cells were lysed and nuclear and 
cytoplasmic fractions were separated using NE-PER Nuclear and Cyto-
plasmic Extraction Reagents. The protein concentration was measured 
with BCA Protein Assay. From 3-4 cortical hemispheres, we could 
get 91.69 µg cytoplasmic protein, and 15.49 µg nuclear protein for 
astrocytes. The respective yield for the neuronal fraction was 85.07 µg 
cytoplasmic and 13.99 µg nuclear protein (Table 2). 
Cell Viability
Cell viability was visualized using a fluorescence-based Live/Dead 
Cell Viability assay. Dead and live cells were distinguished by propid-
ium iodide and calcein-AM, respectively, which were incubated with 
the cells immediately after isolation. Approximately 97.3% ACSA-2 
positive astrocytes are viable (2.7% cell death) and 73% neurons are 
viable (27% cell death, see troubleshooting) (Fig. 1).
Cell Purity
For immunocytochemistry, cells were plated into a BD BioCoat 
96-well plate. Cells were kept at 37°C in a humidified incubator with 
5% CO2 in Neurobasal Medium with 2% B-27 and 0.5 mM GlutaMax 
supplement. After 2 days cultured in vitro, cells were fixed with 4% 
Paraformaldehyde in PBS at room temperature and stained with specific 
cell markers for astrocytes (GFAP), neurons (MAP2 and Doublecortin 
(Dcx)) and microglia (Iba1) (Fig. 2-4). The percentage of GFAP-positive 
cells was 92% from astrocyte preparation (n=3), and MAP2-positive 
cells accounted for 85.79% from neuron preparation (n=3). 
Table 1. Cell count after subsequent separation steps using a starting 
material of 4 cortical hemispheres (two representative cell counts). 
Type of cells
Cell count
n1 n2
After myelin removal 5.69 × 106 6.66 × 106
Astrocytes 2.28 × 106 2.28 × 106
Neurons 0.98 × 106 0.88 × 106
Non-neuronal cells 1.99 × 106 2.20 × 106
Table 2. Protein yield of isolated cells in µg using 3-4 cortical hemi-
spheres (n=4).
Nuclear fraction Cytosolic fraction
Astrocytes 15.49 91.69
Neurons 13.99 85.07
TROUBLESHOOTING
In the following section the most common issues and some solutions 
are listed. Additional help with troubleshooting can be found in the 
company’s detailed data sheets. 
Cell Yield
Make sure the tissue is completely dissociated before the labeling 
and separation of the cells is started. The automated programs of the 
MACS Tissue Dissociator can be repeated as needed. All tissue should 
be in the range of the rotor of the C Tube to ensure a proper dissociation. 
During incubation of the solution at 37°C, constant slow agitation can 
help to equally dissociate the tissue. A rotator can be placed in a 37°C 
incubator for this purpose. 
Figure 1. Live/Dead Cell Viability 
assay of freshly isolated cells. 
Dead cells were stained with EthD-
1 (red), live cells were stained with 
Calcein-AM (green). A. ACSA-2 
positive astrocytes, 2.7% cell 
death. B. Neuronal cells, 27% 
cell death.
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Figure 2. Purity of astrocytes after magnetic isolation and 2 days cultured in vitro. Cells were stained with DAPI (blue), Iba1 (red in A), MAP2 (red 
in C), GFAP (green in A, C; red in B), Dcx (green in B). The last panels are the merged images.
Figure 3. Purity of neurons after magnetic isolation and 2 days cultured in vitro. Cells were stained with DAPI (blue), Iba1 (red in A), MAP2 (green 
in A; red in B), GFAP (green in B; red in C), Dcx (green in C). The last panels are the merged images. 
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Figure 4. Non-neuronal cells after magnetic isolation and 2 days cultured in vitro. Cells were stained with DAPI (blue), Iba1 (red), MAP2 (green in 
B), GFAP (green in A). The last panels are merged images. 
Cell Viability
To increase the viability of the cells, fast processing is crucial. After 
the dissociation steps, using pre-cooled solutions and a cooled centrifuge 
can help to protect the cells. 
Many dead cells in the neuronal fraction: The sorting of neurons is 
based on negative depletion of the non-neuronal cells. Dead cells that are 
not labeled and removed with the Non-Neuronal Cells Biotin-Antibody 
Cocktail could be left in the flow through with the neuronal fraction. 
Due to non-specific staining, dead cells can be labeled and retained by 
the microbeads as well. To increase this effect of non-specific removal 
of dead cells the antibody concentration can be increased. The use of 
LD Columns (Miltenyi Biotec, # 130-042-901) can additionally help 
to sort out the dead cells, since it creates a higher magnetic gradient 
and thereby retains labeled cells more effectively. However a higher 
loss of neurons to the retained fraction due to non-specific staining has 
been observed which may result in lower yield.
Purity
Using a different type of separation column can help to improve the 
purity. Expected number of labeled cells and capacity of the column 
should be taken into consideration. The design of the LD Column is 
optimized for negative depletion of cells and could improve the purity 
of the neuron isolation. However, cell yield could be suffered by higher 
cell loss. 
CONCLUSIONS 
While isolation of ACSA-2-positive astrocytes has been tested for 
mice younger than eight days (< P8) [9], and isolation of “untouched” 
neurons was only tested from P1 mice [10], our protocol shows that 
astrocytes and neurons could be successfully isolated from P9 - P10 
CD-1 mice. Our magnetic cell sorting technique allows simultaneous 
preparation of fresh, pure and viable astrocytes and neurons from 
the same injured neonatal mouse brain, rather than from different 
brain samples, and thereby provides the opportunity to investigate the 
properties and interplay of viable cells directly ex vivo. These freshly 
isolated cells could be used immediately for downstream applications, 
such as FACS or fluorescence microscopy for further characterizing 
subpopulations and activation states of cells; real-time PCR or western 
blotting for evaluation of induced gene transcription and translation 
patterns in individual cell types. These applications represent more 
closely the behavior of the cells in vivo at the time of isolation than the 
in vitro injury paradigm on primary cells. It can help us understand the 
role of one or more particular cell types in physiology and shed light 
into highly complex cellular based injury responses in a disease setting. 
LIMITATIONS
1. Although the purity of astrocytes (92%) and neurons (85.79%) 
is high with our procedure, we do see contamination of other 
cell types (DAPI-positive cells without staining of GFAP or 
MAP2/Dcx). These could be either other subpopulations of 
astrocytes that do not express GFAP or other neuron subtypes 
that do not express MAP2/Dcx, or other cells types resulting 
from non-specific labeling. FACS analysis using more cell 
specific markers would help identify these cells.
2. There are some MAP2-positive cells in the populations of 
“Non-neurons”, which suggests that the efficiency of neu-
ron-sorting is not high enough, although the yield of neurons 
is good enough for subsequent downstream analysis (Fig. 4). 
This could be improved by repeating the steps of non-neu-
ronal cell depletion to recover all neurons remained in the 
non-neuronal fractions.
3. Although ACSA-2 is a specific marker for astrocytes, it 
co-expresses with other common astrocyte markers such as 
GLAST (EAAT-1), GFAP and S100β  [9]. The question remains 
whether ACSA-2 labels all astrocytes in our brain samples 
or whether it represents a subpopulation of astrocytes. The 
heterogeneity of astrocytes is poorly understood; therefore, 
further work is needed for a comprehensive classification of 
astrocyte subtypes and neuron subtypes in our preparations.
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